Qualigen Therapeutics Inc.
QLGN | NASDAQ
$3.21
+$0.17 (+5.59%)
At close: Nov 18, 2025, 04:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -22.9M | -20.4M | -16.97M | -7.23M | -6.98M | -6.77M | -6.16M | -7.77M | -9.17M | -11.2M | -12.15M | -18.21M | -17.93M | -18.55M | -19.89M | -17.42M | -17.55M | -20.39M | -19.74M | -6.53M | -11.61M | -23.22M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.5K | 4.5K | 127.28K | 127.28K | 232.78K | 322.33K | 291.36K | 375.6K | 354.83K | 350.88K | 340.89K | 338.28K | 330.28K | 323.67K | 324.73K |
Stock-Based Compensation | n/a | n/a | 269 | 9.38K | 36.59K | 69.68K | 128.06K | 188.64K | 303.83K | 924.66K | 1.12M | 2.43M | 3.7M | 4.47M | 5.48M | 5.53M | 5.44M | 5.3M | 5.29M | 5.09M | 4.99M | 4.06M |
Other Working Capital | -697.67K | 50.94K | 2M | -72.6K | -193.69K | -389.62K | -338.44K | 466.87K | 1.04M | 284.84K | -441.25K | 99.14K | 435.25K | -304.42K | -827.17K | -1.07M | -1.42M | -942.66K | 1.68M | 556.86K | -932.66K | -790.4K |
Other Non-Cash Items | 11.53M | 10.56M | 8.34M | 336.38K | 621.18K | 20.07K | 487.21K | -3.26M | 59.36K | 619.94K | -96.89K | 8.39M | 3.99M | 3.71M | 3.07M | 117.61K | -1.14M | -1.62M | -2.84M | -14.6M | -8.61M | 8.05M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 572.47K | 572.47K | 161.81K | 161.81K | -410.66K | -410.66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -830.35K | -18.17K | 1.68M | -219.04K | -433.19K | -450.44K | -783.58K | 533.48K | 1.38M | 1.06M | 925.71K | 1.09M | 1.01M | -261.75K | -876.79K | -1.1M | -878.03K | -163.51K | 2.21M | 438.18K | -1.86M | -1.46M |
Operating Cash Flow | -12.2M | -9.86M | -6.95M | -7.1M | -6.76M | -7.13M | -6.33M | -9.73M | -7M | -8.45M | -10.3M | -6.87M | -10.98M | -12M | -13.25M | -13.92M | -13.77M | -16.53M | -14.73M | -15.27M | -16.76M | -12.24M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -4 | -4 | 246.42K | 198.01K | 198.02K | -46.36K | -229.29K | -194.74K | -244.37K | -17K | -90.16K | -121.99K | -141.36K | -196.6K | -373.92K | -725.93K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -135.35K | n/a | n/a | n/a | 135.35K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 1.52M | 305K | n/a | -1.52M | -1.52M | -305K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.82M | 8.82M | 8.82M | 8.82M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -14.56M | -25.6M | -17.4M | -2.82M | -3.78M | -2.21M | -1.91M | -664.6K | 4.57M | 4.17M | 3.97M | 3.49M | -430.18K | -246.42K | -48.41K | -8.62M | -8.68M | -8.82M | -8.83M | 584.94K | 425.48K | 136.63K |
Investing Cash Flow | -13.05M | -24.08M | -15.88M | -2.82M | -3.78M | -2.21M | -1.91M | -664.6K | 4.81M | 4.41M | 4.22M | 3.74M | -502.05K | -332.15K | -183.76K | 43.6K | 45.2K | -121.99K | -141.36K | 395.22K | 217.91K | -134.1K |
Debt Repayment | -3.5M | -882K | n/a | 1.83M | 2.86M | 1.25M | 975.98K | 1.48M | 1.04M | 35K | -440K | 2.46M | 2.9M | 2.9M | 2.9M | n/a | n/a | -15.61K | -138.74K | -426.57K | -804.77K | 17.33K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -1.69M | -1.7M | -1.7M | -1.59K | -89.19K | -87.6K | -87.6K | -87.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 33.98M | 42.69M | 42.69M | 1.27M | 1.36M | 4.8M | 4.8M | 127.6K | 40K | -110K | -110K | -505 | -505 | -505 | 3.35K | -667.34K | -537.91K | -488.18K | -247.45K | 13.16M | 30.2M | 30.15M |
Financial Cash Flow | 25.5M | 40.11M | 40.99M | 48.3M | 10.75M | 9.28M | 9.01M | 4.83M | 1.08M | -75K | -550K | 2.46M | 2.91M | 2.91M | 2.91M | 8.16M | 8.28M | 8.32M | 8.43M | 12.73M | 29.39M | 34.17M |
Net Cash Flow | 245.73K | 6.17M | 18.16M | 38.39M | 212.92K | -63.01K | 772.81K | -1.69M | -1.22M | -4.27M | -2.76M | -675.93K | -4.54M | -5.37M | -10.5M | -5.7M | -5.48M | -8.34M | -6.44M | -25.97M | -10.97M | -2.03M |
Free Cash Flow | -12.2M | -9.86M | -6.95M | -7.1M | -6.76M | -7.13M | -6.33M | -9.73M | -6.75M | -8.26M | -10.11M | -6.92M | -11.21M | -12.19M | -13.49M | -13.94M | -13.86M | -16.65M | -14.87M | -15.47M | -17.13M | -12.97M |
Adj. Free Cash Flow | -12.2M | -9.86M | -6.95M | -7.11M | -6.79M | -7.2M | -6.46M | -9.92M | -7.06M | -9.18M | -11.22M | -9.35M | -14.91M | -16.66M | -18.98M | -19.47M | -19.3M | -21.95M | -20.17M | -20.56M | -22.12M | -17.03M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -4 | -4 | 246.42K | 210.98K | 210.99K | -33.39K | -194.54K | -159.1K | -208.73K | 35.65K | -49.63K | -76.45K | -56.78K | -56.78K | -243.75K | -614.63K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.97K | -12.97K | -12.97K | -34.76K | -35.65K | -35.64K | -52.65K | -40.53K | -45.54K | -84.59K | -139.83K | -130.16K | -111.3K |
Owner Earnings | -12.2M | -9.86M | -6.95M | -7.1M | -6.76M | -7.13M | -6.33M | -9.73M | -6.75M | -8.24M | -10.09M | -6.9M | -11.18M | -12.16M | -13.46M | -13.89M | -13.82M | -16.61M | -14.79M | -15.33M | -17M | -12.86M |
Add to Watchlist
Select watchlists to add or remove QLGN